top of page
Executive Spotlights

XtalPi Partners with Eli Lilly in Groundbreaking $250M Collaboration, Utilizing AI and Robotics

Cambridge, MA, May 30, 2023 (PRNewswire) -- XtalPi, a leading pharmaceutical technology company, has joined forces with Eli Lilly and Company in a cutting-edge collaboration leveraging artificial intelligence (AI) and automation to discover innovative therapeutics. With XtalPi's state-of-the-art AI drug discovery platform and robotics capabilities, this partnership aims to deliver first-in-class compounds for undisclosed targets, revolutionizing the drug development process and advancing patient care.

Read full article here.

Recent Posts

See All

AxoSim appoints Alif Saleh as CEO

New Orleans, LA, June 14, 2024 (Indian Pharma Post) -- AxoSim, a life science firm specializing in lab-grown human brains, has appointed Alif Saleh as its new CEO. Salef, a company builder, brings e


Life Science Headlines
bottom of page